Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
life sciences
merck
6
×
national
national blog main
6
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
6
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
pfizer
biogen
cancer
deals
moderna
novartis
roche
alzheimer's disease
biontech
bristol-myers squibb
clinical trials
What
bio
roundup
6
×
drug
patients
acquisitions
biggest
buy
ceo
crispr
moves
pricing
advanced
advantages
albert
alliance
arrival
award
bar
becker
billions
bourla
brings
bristol
build
calls
cancer
changing
color
company
company’s
daniel
data
days
death
debut
decades
dems
dollars
dyne’s
eaton
Language
unset
unknown
Current search:
merck
×
amgen
×
" national blog main "
×
" wisconsin top stories "
×
roundup
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More